DK2018158T3 - Ny racecadotril administrationsform - Google Patents

Ny racecadotril administrationsform

Info

Publication number
DK2018158T3
DK2018158T3 DK07731453.2T DK07731453T DK2018158T3 DK 2018158 T3 DK2018158 T3 DK 2018158T3 DK 07731453 T DK07731453 T DK 07731453T DK 2018158 T3 DK2018158 T3 DK 2018158T3
Authority
DK
Denmark
Prior art keywords
racecadotril
new
administration form
administration
racecadotril administration
Prior art date
Application number
DK07731453.2T
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37552919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2018158(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Application granted granted Critical
Publication of DK2018158T3 publication Critical patent/DK2018158T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK07731453.2T 2006-05-15 2007-05-14 Ny racecadotril administrationsform DK2018158T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604302A FR2900823B1 (fr) 2006-05-15 2006-05-15 Nouvelle forme d'administration du racecadotril.
PCT/FR2007/000814 WO2007132091A1 (fr) 2006-05-15 2007-05-14 Nouvelle forme d'administration du racecadotril

Publications (1)

Publication Number Publication Date
DK2018158T3 true DK2018158T3 (da) 2013-07-22

Family

ID=37552919

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07731453.2T DK2018158T3 (da) 2006-05-15 2007-05-14 Ny racecadotril administrationsform

Country Status (28)

Country Link
US (1) US8318203B2 (da)
EP (1) EP2018158B1 (da)
KR (1) KR101432116B1 (da)
CN (2) CN101442990A (da)
AP (1) AP2627A (da)
AU (1) AU2007251471B2 (da)
BR (1) BRPI0710405B8 (da)
CA (1) CA2652023C (da)
CY (1) CY1114190T1 (da)
DK (1) DK2018158T3 (da)
EA (1) EA014707B1 (da)
EC (1) ECSP088889A (da)
ES (1) ES2421929T3 (da)
FR (1) FR2900823B1 (da)
HR (1) HRP20130624T1 (da)
IL (1) IL195270A (da)
MA (1) MA30466B1 (da)
MX (1) MX2008014554A (da)
NO (1) NO342977B1 (da)
NZ (1) NZ573424A (da)
PL (1) PL2018158T3 (da)
PT (1) PT2018158E (da)
RS (1) RS52912B (da)
SI (1) SI2018158T1 (da)
TN (1) TNSN08428A1 (da)
UA (1) UA98299C2 (da)
WO (1) WO2007132091A1 (da)
ZA (1) ZA200809721B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
CN102133186B (zh) * 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
CN104411299B (zh) * 2012-06-28 2017-11-10 麦克内尔-Ppc股份有限公司 消旋卡多曲类脂组合物
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
EP2749270B1 (en) * 2012-12-26 2018-01-17 ILKO Ilaç Sanayi ve Ticaret A.S. Racecadotril and pharmaceutical compositions thereof
JP2017500355A (ja) * 2013-12-23 2017-01-05 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド ラセカドトリル組成物
EP2918268A1 (en) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
US10188607B2 (en) * 2015-02-09 2019-01-29 Rivopharm Sa Pharmaceutical formulation of racecadotril
CN106822907B (zh) * 2016-12-29 2021-02-09 山东达因海洋生物制药股份有限公司 一种含消旋卡多曲的双相释放制剂及其制备方法
RU2749949C2 (ru) * 2017-03-06 2021-06-21 Атена Фармасьютикс Сас Фармацевтическая композиция, содержащая рацекадотрил, и способ ее получения

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
CA2415957C (en) 2000-06-23 2010-08-10 Bioprojet Dry powder formulation comprising racecadotril
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
EP1563848A1 (en) 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
NZ553561A (en) * 2004-08-13 2010-12-24 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome

Also Published As

Publication number Publication date
MA30466B1 (fr) 2009-06-01
BRPI0710405B8 (pt) 2021-05-25
BRPI0710405B1 (pt) 2019-01-08
IL195270A0 (en) 2009-08-03
ZA200809721B (en) 2009-06-24
UA98299C2 (ru) 2012-05-10
SI2018158T1 (sl) 2013-09-30
NZ573424A (en) 2012-03-30
HRP20130624T1 (en) 2013-08-31
TNSN08428A1 (fr) 2010-04-14
US8318203B2 (en) 2012-11-27
RS52912B (sr) 2014-02-28
AP2008004686A0 (en) 2008-12-31
US20090186084A1 (en) 2009-07-23
EP2018158A1 (fr) 2009-01-28
MX2008014554A (es) 2008-11-27
AP2627A (en) 2013-03-26
AU2007251471B2 (en) 2012-03-15
EA200802324A1 (ru) 2009-04-28
PL2018158T3 (pl) 2013-09-30
CA2652023C (fr) 2016-06-28
KR101432116B1 (ko) 2014-08-21
AU2007251471A1 (en) 2007-11-22
BRPI0710405A2 (pt) 2011-08-09
ES2421929T3 (es) 2013-09-06
ECSP088889A (es) 2009-01-30
WO2007132091A1 (fr) 2007-11-22
FR2900823B1 (fr) 2009-02-13
NO20084826L (no) 2008-12-12
NO342977B1 (no) 2018-09-17
KR20090017593A (ko) 2009-02-18
CA2652023A1 (fr) 2007-11-22
FR2900823A1 (fr) 2007-11-16
PT2018158E (pt) 2013-07-24
IL195270A (en) 2016-08-31
EP2018158B1 (fr) 2013-04-24
EA014707B1 (ru) 2011-02-28
CN103961328A (zh) 2014-08-06
CY1114190T1 (el) 2016-08-31
CN101442990A (zh) 2009-05-27

Similar Documents

Publication Publication Date Title
NO2021010I1 (no) telostritat ethyl
DK2018158T3 (da) Ny racecadotril administrationsform
CY2018030I1 (el) Φαρμακοτεχνικη μορφη 514
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
EP3777939C0 (en) NASAL ROYALTY
DK1986650T3 (da) Manipulationssikre doserignsformer
BRPI0715712A2 (pt) Composição farmacêutica
EP1984009A4 (en) PHARMACEUTICAL COMPOSITIONS WITH IMPROVED STABILITY
DK2041139T3 (da) Farmaceutiske forbindelser
BRPI0820381A2 (pt) Formulações farmacêuticas
DK2068886T3 (da) Lipidholdige præparater
ATE450271T1 (de) Impfstoff
BRPI0719393A2 (pt) Composição farmacêutica
DK2399579T3 (da) Farmaceutiske doseringsformer
EP2124556A4 (en) PHARMACEUTICAL COMPOSITIONS
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
DK2035369T3 (da) Terapeutiske
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
HUE062920T2 (hu) Eljárások vakcina beadására
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
DK2131818T3 (da) Ny doseringsform
BRPI0913709A2 (pt) "formulação farmacêutica"
DK2001445T3 (da) Farmaceutiske sfæroider
DE602007002796D1 (de) Schnellabgabegranulat